Iščem...
Iskalni niz je ali predolg ali pa vsebuje preveč besed.
Prevodi: en > sl
1–16/16
yeast culture
1 Objavljeno
RS
DRUGO: TRANS
In spite of the prophylaxis with ketoconazole or fluconazole and treatment with amfotericin B, we isolated fungi from sputum and stool more often than before antifungal prophylaxis. The yeast Canadida albicans was isolated from all surveillance cultures, before antifungal prophylaxis, during prophylaxis with ketoconazole or fluconazole, and during treatment with amfotericin B most frequently.(trunc.)
Najpogosteje smo iz nadzornih kužnin pred in med profilakso s ketonazolom ali flukanazolom ter med zdravljenjem z amfotericinom B osamili glivo Candida albicans.(krajš.)
2 Pravna redakcija
gospodarstvo
CELEX: 31980R3448
Culture yeast
kultura kvasa
3 Pravna redakcija
promet
CELEX: 32002R2286
Culture yeasts
Kultura kvasa
4 Pravna redakcija
promet
- Culture yeast
- kultura kvasa
5 Pravna redakcija
promet
- - Culture yeast
-- kultura kvasa
6 Pravna redakcija
CELEX: 22003D0038
vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similarproducts:
cepiva, toksini, kulture mikroorganizmov (razen kvasovk) in podobni izdelki:
7 Pravna redakcija
DRUGO
vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products:
cepiva, toksini, kulture mikroorganizmov (razen kvasovk) in podobni proizvodi:
8 Pravna redakcija
promet
Antisera; microbial vaccines, toxins, microbial cultures (including ferments but excluding yeasts) and similar products:
Antiserumi; mikrobna cepiva, toksini, mikrobne kulture (vključno fermenti, razen kvasa) in podobni izdelki:
9 Pravna redakcija
promet
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products:
Človeška kri; živalska kri, pripravljena za uporabo v terapevtske, profilaktične ali diagnostične namene; antiserumi in druge frakcije krvi; cepiva, toksini, kulture mikroorganizmov (razen kvasovk) in podobni izdelki:
10 Pravna redakcija
promet
CELEX: 32001D0822
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products:
Človeška kri; živalska kri, pripravljena za uporabo v terapevtske, profilaktične ali diagnostične namene; antiserumi in druge frakcije krvi ter modificirani imunološki proizvodi, dobljeni po biotehničnih postopkih; cepiva, toksini, kulture mikroorganizmov (razen kvasovk) in podobni proizvodi:
11 Pravna redakcija
promet
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products:
Človeška kri; živalska kri, pripravljena za uporabo v terapevtske, profilaktične ali diagnostične namene; antiserumi in druge frakcije krvi ter modificirani imunološki proizvodi, dobljeni po biotehničnih postopkih ali kako drugače; cepiva, toksini, kulture mikroorganizmov (razen kvasovk) in podobni proizvodi:
12 Pravna redakcija
promet
Human blood; animal blood prepared for therapeutic; prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of mirro-organisms (excluding yeasts) and similar products::
Človeška kri; živalska kri, pripravljena za uporabo v terapevtske, profilaktične ali diagnostične namene; antiserumi in druge frakcije krvi ter modificirani imunološki proizvodi, pridobljeni po biotehničnih postopkih ali kako drugače; cepiva, toksini, kulture mikroorganizmov (razen kvasovk) in podobni izdelki:
13 Prevajalska redakcija
RS
EMEA
HBsAg is produced by culture, in a selective medium, of genetically engineered yeast cells.
HBsAg je pridobljen z gensko tehnologijo na kulturi celic kvasovk v selektivnem mediju.
14 Prevajalska redakcija
RS
EMEA
The surface antigen of hepatitis B virus is produced by culture of a recombinant strain of yeast cells (Saccharomyces cerevisiae).
Površinski antigen virusa hepatitisa B proizvaja rekombinantni sev kvasovk (Saccharomyces cerevisiae).
15 Prevajalska redakcija
RS
EMEA
The surface antigen of the HBV (HBsAg) is produced by culture of genetically-engineered yeast cells (Saccharomyces cerevisiae) which carry the gene coding for the major surface antigen of the HBV.
Površinski antigen HBV (HBsAg) je pridobljen z genetskim inženiringom na kulturi celic kvasovk (Saccharomyces cerevisiae), ki so nosilec gena, ki kodira glavni površinski antigen HBV.
16 Prevajalska redakcija
RS
EMEA
These components are the Haemophilus influenzae type b capsular polysaccharide (PRP) that is covalently bound to an outer membrane protein complex (OMPC) of Neisseria meningitidis and hepatitis B surface antigen (HBsAg) from recombinant yeast cultures.
Ti sestavini sta kapsulni polisaharid (PRP) Haemophilusa influenzae tipa b, kovalentno vezan na beljakovinski kompleks zunanje membrane (OMPC) Neisserie meningitidis, ter površinski antigen hepatitisa B (HBsAg) iz rekombinantnih kultur kvasovk.
Prevodi: en > sl
1–16/16
yeast culture